Health Insurers Sink on Sanders’ Medicare for All Plan
US health insurance stocks experienced a significant downturn following announcements of new federal audits for Medicare and Senator Bernie Sanders' proposals for expanded Medicare eligibility. UnitedHealth Group Inc., the largest insurer, saw its shares drop by as much as 21%, wiping out almost all its year-to-date gains due to these developments.
Humana (HUM) Stock Trending After Hours as CMS Proposes $90B Medicare Anti-Fraud Rule
Humana (HUM) shares were trending after hours, slipping 0.46% following the Centers for Medicare & Medicaid Services (CMS) proposal of a new anti-fraud rule. This rule, which targets fraud, waste, and abuse across several healthcare programs, could save taxpayers nearly $90 billion over 10 years. For insurers like Humana, the primary change involves stricter Medicare Advantage Risk Adjustment Data Validation audits to recover improper payments.
Humana Drops 6.4% Amid Sector-Wide Selling
Humana Inc. shares fell 6.4% to $415.14, caught in a broad sector-wide selloff affecting managed care and health insurance stocks. The decline was not company-specific, as peers like UnitedHealth Group and Elevance Health also saw significant drops, suggesting broader market concerns rather than individual company issues. Despite the sharp decline, analyst sentiment remains constructive with no recent price target cuts, indicating that Wall Street's view of Humana's fundamentals has not materially shifted.
Cytokinetics chief legal officer sells $794,877 in shares
Jeffrey Hessekiel, Cytokinetics' Chief Legal & Admin Officer, sold 15,106 shares of the company's common stock for $794,877 to cover tax withholding obligations. This "sell to cover" transaction was mandated and not discretionary, occurring while the stock trades near its 52-week low. Despite recent strong Q3 2026 financial results, analysts and InvestingPro still consider the stock undervalued with optimistic price targets.
Humana Drops 6.4% Amid Sector-Wide Selling
Humana Inc. shares dropped 6.4% on Wednesday, reflecting a broad sector-wide selloff that impacted managed care and health insurance stocks like UnitedHealth Group, Elevance Health, Centene, Molina Healthcare, and Clover Health. The decline was not company-specific, suggesting broader concerns about the healthcare coverage sector rather than Humana's fundamentals. Despite the drop, analyst sentiment remains constructive, with no recent price target cuts.
Molina Healthcare Drops 5.9% Amid Sector-Wide Selling
Molina Healthcare's stock fell 5.9% on Wednesday, closing at $208.22, as part of a broad selloff impacting managed care companies. Major competitors like UnitedHealth Group, Humana, Centene, Elevance Health, and Clover Health also experienced significant declines, indicating a sector-wide retreat rather than company-specific issues for Molina. The synchronized drop suggests a shift in investor sentiment regarding the managed care industry's outlook or risk profile.
Macy’s Jumps 5.4% Amid Sector-Wide Rally
Macy's stock surged 5.4% to $24.65 on Wednesday, participating in a broad rally that also lifted other retail sector peers like Dillard's, Etsy, and Ollie's Bargain Outlet. The move appeared to be driven by a shift in sentiment towards consumer-facing names rather than any company-specific news for Macy's, with its market cap now at $6.4 billion. The sustainability of this rally will depend on broader sector sentiment and potential future fundamental catalysts.
Centene Corp. stock underperforms Wednesday when compared to competitors
Centene Corp. (CNC) stock fell 7.03% on Wednesday, closing at $67.45, underperforming the broader market. The S&P 500 Index (SPX) declined 0.23%, and the Dow Jones Industrial Average (DJIA) fell 1.11%, making it the second consecutive day of losses for Centene's stock.
Wafd stock hits 52-week low at 28.1 USD
WaFd Inc.'s stock has fallen to a 52-week low of $28.10, reflecting decreased investor confidence and a 9.76% decline over the past year. Despite this, InvestingPro analysis suggests the stock is undervalued with a P/E ratio of 8.82 and a PEG ratio of 0.4, indicating potential for near-term earnings growth. The company also maintains a consistent dividend payment history for 44 consecutive years, offering a 3.82% yield.
Zacks Industry Outlook Highlights UnitedHealth, The Cigna, Humana, Centene and Molina
The U.S. health insurance (HMO) industry faces both opportunities and challenges, with diversified health plans and an aging population supporting membership and demand for Medicare. Regulatory changes like Medicaid eligibility checks and expired ACA subsidies threaten enrollment, while technological advancements like AI and telehealth improve efficiency but carry implementation costs. Industry leaders like UnitedHealth Group, Cigna, Humana, Centene, and Molina Healthcare are well-positioned to leverage these dynamics, supported by strategic acquisitions and an optimistic Zacks Industry Rank.
UnitedHealth Group falls 5.42% in Tuesday's session
UnitedHealth Group shares experienced a significant drop, trading 5.42% below their previous close at $389.68 on November 17, 2026. The company's market capitalization stood at $353.89 billion in the United States health care sector. This decline was reported after the market closed, with the last traded price differing from the exchange's official closing price.
Medicare, Medicaid Overhaul Targets Fraudulent Billing and Unauthorized Marketplace Enrollments
The Centers for Medicare & Medicaid Services (CMS) has proposed significant program integrity reforms aimed at combating fraud, waste, and abuse across federal healthcare programs, potentially saving nearly $90 billion over the next decade. The "Comprehensive Regulations to Uncover Suspicious Healthcare" rule strengthens Medicare Advantage audits, mandates reporting of suspected fraud, and protects seniors from unwanted solicitations. Additionally, it tightens oversight for Medicaid and CHIP and prevents unauthorized enrollments in the Health Insurance Marketplace.
Bernstein raises Centene stock price target to $90 on Medicaid outlook
Bernstein SocGen Group raised its price target on Centene Corp. (NYSE:CNC) to $90 from $79 and maintained an Outperform rating, citing strong third-quarter results and improved Medicaid recovery prospects. The firm also increased its adjusted earnings per share estimates for fiscal years 2026, 2027, and 2028, and lowered its medical loss ratio expectation for 2027 and 2028. Centene's Q3 2026 adjusted EPS of $0.58 significantly beat consensus, and the company raised its full-year EPS and revenue guidance, leading to positive responses from other analyst firms as well.
UnitedHealth Stock Drops 4%: What’s Going On?
UnitedHealth Group (NYSE:UNH) shares dropped after Senator Elizabeth Warren called for breaking up major healthcare conglomerates, including UnitedHealth, citing concerns over their vertical integration and influence on patient care. Concurrently, the Centers for Medicare & Medicaid Services (CMS) proposed new "CRUSH" rules to combat healthcare fraud, waste, and abuse, further impacting the sector. These combined pressures led to a significant decline in UnitedHealth's stock price.
Welltower and Ventas Are Riding the Same Senior Housing Boom, but Their Valuations Tell Different Stories
Welltower and Ventas, two senior housing REITs, are both benefiting from the aging Baby Boomer population and record-low senior housing construction. While Welltower shows stronger growth with 21% same-store NOI increases and a significant deal pipeline, its stock trades at a premium 38x FFO. Ventas, conversely, offers a higher dividend yield of 2.3% and a lower valuation at 23x FFO, making it potentially more attractive for retirement-focused income investors despite its slower growth and higher leverage.
Elastic NV. (ESTC) PT Lowered to $85 at TD Cowen Amid 'Tougher Setup'
TD Cowen analyst Andrew Sherman has lowered the price target for Elastic NV. (ESTC) to $85 from $95, maintaining a Hold rating. The revision comes amidst a "tougher setup" for the company, citing cautious industry checks, increasingly negative sales rep reviews, and significant insider selling, despite expectations for a modest beat in sales-led subscriber growth. Sherman anticipates higher expectations for Elastic NV. after its recent stock performance, making the upcoming earnings print a more challenging event.
Warren Buffett Just Gave Away $5.5 Billion of Berkshire Stock Without Selling a Share. Here's His Rule for a 72-Year-Old With $400,000 in Berkshire Who Gives $20,000 a Year to Her Church
Warren Buffett recently donated $5.5 billion worth of Berkshire Hathaway stock to family foundations without selling any shares, illustrating a tax-efficient giving strategy. The article extends this principle to a 72-year-old individual holding $400,000 in Berkshire stock who wishes to donate $20,000 annually to her church. It outlines three methods for charitable giving, demonstrating that donating shares directly or using a qualified charitable distribution from an IRA can significantly reduce tax liabilities compared to selling shares for cash.
CMS gives states another 6 months to implement Medicaid work requirements
The CMS has granted states a six-month delay, until June 30, to implement Medicaid work requirements, allowing more time to prepare systems for eligibility checks. States can apply for this "hold harmless" option by December 11, extending the original January 1 deadline. This decision comes after states struggled with IT system readiness and pushed back against the requirements, with some industry groups praising the delay to prevent beneficiaries from losing coverage due to administrative issues.
American Financial Group stock hits 52-week low at 19.2 USD
American Financial Group Inc. (AFGD) stock has fallen to a 52-week low of $19.2, down from a high of $22.92, though shares are currently trading at $19.33. InvestingPro analysis indicates the stock is oversold, potentially presenting a buying opportunity, given its 7.21% dividend yield and a P/E ratio of 12.6, despite a -3.14% return over the past year.
Private Equity and Private Credit Firms Manage Trillions, and $90,000 Across These 3 Pays $3,389 a Year in Dividends
Private equity and private credit firms like Ares, Blackstone, and Carlyle Group offer a way for everyday investors to generate significant dividend income, despite typically requiring millions of dollars for direct fund access. An investment of $90,000 spread across these three firms could yield an annual passive income of $3,389. While Carlyle pays a fixed dividend, Ares offers the highest yield but with tighter payout coverage, and Blackstone's payout is variable, reflecting its distributable earnings policy.
3 High-Yield Storage REITs Are Rallying After Raising Their 2026 Outlooks
Three high-yield self-storage REITs—Public Storage, Extra Space Storage, and CubeSmart—have seen their stocks rally over the past month after raising their full-year 2026 FFO guidance. The sector is recovering from a two-year period of absorbing new facilities, with easing new supply and consistent demand driving improved outlooks. All three companies offer strong dividend coverage with FFO, though they present different risk profiles and yield levels for income investors.
Molina Healthcare Jumps 7.5% Amid Sector-Wide Rally
Molina Healthcare (MOH) shares surged 7.5% to $225.25 on November 16, 2026, as part of a broader rally in managed care stocks, pushing its market capitalization to $11.8 billion. Other sector peers like Elevance Health (ELV) and Centene Corporation (CNC) also saw gains. The rally suggests strong investor interest in the healthcare plans sector, though no specific company catalyst was identified for Molina's outperformance, indicating macro factors or portfolio repositioning as potential drivers.
Rigetti Computing stock hits 52-week low at $9.19
Rigetti Computing Inc.'s stock has fallen to a 52-week low of $9.19, marking a 62.24% decline over the past year. Despite recent technological achievements like the 108-qubit Cepheus system, the company reported a significant revenue shortfall and adjusted loss for Q3 2026, leading analysts to lower price targets. The stock's high volatility and overvaluation suggest ongoing challenges for the quantum computing firm.
Allarity expands Phase 2 trial of stenoparib to include three ovarian cancer patient groups
Allarity Therapeutics has expanded its Phase 2 clinical trial of stenoparib, an oral cancer drug, to include three distinct groups of advanced ovarian cancer patients: primary platinum-refractory, platinum-resistant, and those with clinically evaluable but non-measurable disease. This expansion aims to build on promising early results, accelerate FDA approval, and potentially provide broader treatment options for ovarian cancer patients. Positive outcomes from this trial could support further development and commercialization of stenoparib.
Molina Healthcare climbs 8% as sector moves higher (MOH:NYSE)
Molina Healthcare (MOH) shares increased over 8% on Monday, adding $16.98 to reach $226.47. This rise occurred as other managed healthcare providers like CNC and ELV also saw gains, with HUM, UNH, and CVS climbing as well. The article notes that the content was AI-generated and intended for informational purposes.
Form 4 Centene Corp: Theodore J. Pienkos (Corporate Controller & CAO) For: 15 September
This article reports a Form 4 filing for Centene Corp, detailing insider transactions by Theodore J. Pienkos, the Corporate Controller & CAO. The filing pertains to activity on September 15. Form 4 filings are mandatory reports that must be filed with the U.S. Securities and Exchange Commission (SEC) whenever there is a change in the ownership of company stock by company officers, directors, or any shareholder owning more than 10% of the company's stock.
Form 4 Centene Corp: Theodore J. Pienkos (Corporate Controller & CAO) For: 15 September
This article reports on a Form 4 filing for Centene Corp concerning Theodore J. Pienkos, the Corporate Controller & CAO, for transactions dated September 15. The brief piece indicates that Centene Corp's stock (CNC) saw a 1.42% increase.
3 Health Insurance Stocks Facing Pressure From GLP 1 Weight Loss Drug Prices
The article discusses how the rising costs of GLP-1 weight loss drugs are impacting health insurance companies, with CVS Health suggesting prices need to drop significantly to be affordable. It highlights three health insurers—Humana (HUM), Molina Healthcare (MOH), and Centene (CNC)—that are particularly exposed to these pricing pressures due to their reliance on Medicare Advantage and government-backed managed care programs. The piece explores how these drug costs could reshape their long-term margin profiles and earnings paths.
Molina Healthcare chief legal officer sells $1.62M in shares
Molina Healthcare's chief legal officer, Jeff D. Barlow, recently sold 8,000 shares of company stock for a total of $1.62 million. This transaction occurred on November 10, 2026, after the stock saw a 52% return over the past year. Despite the sale, Barlow retains a significant number of shares, with more scheduled to vest in the coming years.
A Stockton housing fund backed by Health Net will focus on families earning 30% to 50% of local median income.
Health Net, a Centene Corporation company, announced a $3 million investment in the San Joaquin Regional Housing Fund. This funding will provide grants and low-interest loans to create at least 75 affordable homes for Stockton families, specifically targeting households earning between 30% and 50% of the area median income. This initiative is part of Health Net's broader commitment, having invested a combined $11 million in affordable housing in Sacramento and San Joaquin counties.
Centene Corporation (CNC) Seasonal returns chart
This article displays the seasonal returns chart for Centene Corporation (CNC), showing the average monthly price return from 2016 to 2026. The current stock price for CNC is $74.87, reflecting a 5.05% increase. The data is provided by Yahoo Finance and is current as of 1:06:28 pm GMT-5.
Why Does VFLO Hold More Healthcare Than Its Value Benchmark?
The VictoryShares Free Cash Flow ETF (VFLO) holds a larger percentage in healthcare companies than its benchmark, the Russell 1000® Value Index, not due to a sector call but because healthcare companies generate significant free cash flow. VFLO's underlying index ranks companies based on free cash flow yield and growth, leading to a higher allocation in sectors like healthcare, energy, and information technology compared to traditional value benchmarks. This distinct sector exposure, including the absence of financials, results in a different portfolio composition and a lower forward price-to-earnings ratio for VFLO.
Addus HomeCare EVP Cliff Donald Blessing Sells 2,000 Shares at $124.18 Average Price
Cliff Donald Blessing, EVP and Chief Development Officer of Addus HomeCare Corp (NASDAQ:ADUS), sold 2,000 shares of the company's common stock on November 6, 2026, at a weighted average price of $124.18 per share. This transaction, revealed in a Form 4 filing, leaves Blessing with 10,183 shares of common stock directly owned. The sale involved multiple transactions ranging from $124.02 to $124.34.
HealthSpan Partners ups Surgery Partners offer to $6B after rival bid
HealthSpan Partners, an affiliate of Bon Secours Mercy Health, increased its offer to acquire Surgery Partners to $6 billion, up from $5.7 billion, after the surgical facility network received an unsolicited bid from an undisclosed rival, reportedly UnitedHealth. The new terms offer Surgery Partners shareholders $25.00 per share, with potential additional monthly payments if the deal, expected to close in Q1 next year, is delayed past March 1. Surgery Partners stated the rival bid, while higher at $28.00 per share, would have taken "materially longer to close" and risked regulatory delays.
Did Raised Guidance Just Shift Centene (CNC) Investment Narrative?
Centene reported strong third-quarter 2026 results, showing a significant swing to profit over nine months and raising full-year revenue and GAAP EPS guidance. This performance, driven by management's focus on profitability in government health plans, is expected to influence the investment narrative by narrowing near-term operating risks and providing a concrete yardstick for execution against analyst catalysts. The updated guidance, including a higher revenue range of US$196.5b to US$200.5b and a GAAP diluted EPS floor above US$3.46, reinforces the margin expansion story across its various health segments.
Quest Diagnostics Quanum Breach: Check Patient Data Exposure
Quest Diagnostics disclosed a data breach on its Quanum Lab Services Manager platform, exposing patient names, birthdates, lab requisitions, and diagnostic result metadata. The incident occurred on October 21, 2026, leading to a five-day portal outage. Patients are advised to audit MyQuest history, confirm provider Quanum usage, monitor HIPAA notices, and enforce credit freezes to protect their information.
Centene (CNC) Could Be 5% Undervalued On Raised 2026 Guidance
Centene (CNC) has raised its 2026 revenue and earnings guidance after a strong third quarter and earlier-than-expected Medicare Advantage break-even. Despite a recent slip in share price, the stock shows significant positive returns over 30 days and year-to-date, with analysts suggesting it is approximately 5% undervalued. The company's efforts to restore Medicaid margins further support its earnings power, but future performance could be influenced by health policy changes or unmet expectations in Medicaid recovery and membership trends.
Centene Corporation (CNC) latest stock news and headlines
This article provides a collection of recent news headlines related to Centene Corporation (CNC), detailing various analyst opinions, earnings reports from competitors, and market reactions to midterm election results. It also includes current stock performance data for CNC, showing its year-to-date and 1-year returns compared to the S&P 500. The news suggests a positive outlook for healthcare stocks after the Democratic midterm election victory.
Midday Pulse: S&P 500 top intraday losers
This article highlights the top intraday losers on the S&P 500 on a recent Friday, despite the overall index rising by 0.9%. Companies experiencing significant declines include Axon Enterprises, Microchip Technology, Insulet Corp., Centene Corp., and Gartner. The report quickly summarizes the stock performance for these companies.
Why Is Centene (CNC) Gaining Election Driven Momentum After The U.S. Vote?
Centene (CNC) and other managed care stocks rose after Democrats secured control of both the U.S. House and Senate, leading to expectations of extended Affordable Care Act premium subsidies and reduced risk of federal healthcare spending cuts. While this election outcome is a positive tailwind for Centene's government-program earnings strategy, analysts still flag potential risks related to slower Medicaid margin repair and future policy changes, emphasizing the company's exposure to Washington. The article suggests that investors should consider Centene's margin expansion plans against its policy vulnerability to determine the more likely earnings trajectory.
Centene Corporation (CNC) Seasonal Returns Chart
This article provides a historical seasonality chart for Centene Corporation (CNC), showing the average monthly price return from 2016 to 2026. As of the close, CNC's stock price was $69.74, down 5.97%, and further decreased slightly in after-hours trading. The content also briefly displays various market indices and commodity prices.
Centene Corp. stock underperforms Friday when compared to competitors
Centene Corp. (CNC) shares dropped 5.97% on Friday, closing at $69.74, underperforming the broader market. The S&P 500 Index saw a slight rise, while the Dow Jones Industrial Average experienced a decline. This marks the second consecutive day of losses for Centene's stock.
Axon Enterprise stock hits 52-week low at $334.96
Axon Enterprise Inc.'s stock recently hit a 52-week low of $334.96 and is currently trading at $322.04, reflecting a 10.6% decline in the past week and a 36.51% decline over the past year. The company also reported third-quarter revenue of $908.6 million and adjusted earnings of $1.72 per share, both falling short of Wall Street expectations. Despite these challenges, InvestingPro analysis suggests the stock is currently undervalued.
The Zacks Analyst Blog Highlights Microsoft, Amazon, Alphabet, Nextpower and Centene
This Zacks Analyst Blog highlights how the U.S. midterm election results are shaping the investment landscape, particularly for renewable energy, healthcare, and AI infrastructure stocks. It discusses how policy uncertainty creates opportunities across these sectors, with specific companies like Nextpower Inc., Centene, Microsoft, and Amazon seeing varied market reactions. The article emphasizes the importance of strong fundamentals amid evolving policy and regulatory conditions.
Centene (CNC) Stock Still Looks Cheap As Its 100% Run Continues
Centene (CNC) stock has nearly doubled in the past year, trading around US$74, driven by improving margins and cost cuts. Despite this strong performance, the stock's P/E ratio of 25.2x suggests it may still be undervalued compared to the healthcare industry average and peers. Analysts and community narratives are split, with some seeing further upside potential while others consider it fairly valued based on current earnings and future growth expectations.
Privia Health Reports Strong Third Quarter and Year-to-Date 2026 Results
Privia Health (Nasdaq: PRVA) reported strong third-quarter 2026 results with revenue up 13.2% to $657.0 million and net income attributable to Privia increasing 96.6% to $13.5 million. The company raised its full-year 2026 financial outlook, expecting revenue between $2,500–$2,550 million and adjusted EBITDA of $154–$157 million. Privia also announced the acquisition of American Choice Healthcare MSSP, which will add over 36,000 attributed lives, and its exit from the Montana partnership.
Cigna boosts 2026 outlook as insurance, specialty pharmacy profits climb
Cigna has raised its 2026 financial outlook for the third time this year, driven by strong performance in its health insurance and specialty pharmacy divisions. While overall net income was down, adjusted earnings per share and operating income increased, leading executives to project profitable growth for 2027. However, the company's pharmacy benefits manager, Express Scripts, faced a decline in profits due to a costly transition to a new, more transparent pharmacy benefits model.
Centene Corp stock hits 52-week high at 77.65 USD
Centene Corp (NYSE: CNC) stock has reached a new 52-week high of $77.65, currently trading at $77.87, with a market capitalization of $38.23 billion. This reflects a significant 1-year change of 107.92% and year-to-date returns of 84.7%. The company recently reported strong Q3 2026 results, surpassing earnings expectations, and analysts have raised price targets, indicating confidence in Centene's continued recovery and growth.
Centene Corp stock hits 52-week high at 77.65 USD By Investing.com
Centene Corp (CNC) stock has achieved a new 52-week high of $77.65, with shares currently trading at $77.87 and a market capitalization of $38.23 billion, reflecting a significant 1-year change of 107.92% and year-to-date returns of 84.7%. InvestingPro analysis indicates the stock is undervalued despite its strong performance and recent impressive Q3 2026 results, which surpassed earnings and revenue expectations. Analysts from Jefferies, Cantor Fitzgerald, and BofA Securities have raised their price targets for Centene, citing strong navigation of challenges and an improved margin outlook.
Centene Corp stock hits 52-week high at 77.65 USD By Investing.com
Centene Corp (CNC) stock has reached a new 52-week high of $77.65, currently trading at $77.87, reflecting a 1-year change of 107.92% and year-to-date returns of 84.7%. The company recently reported strong third-quarter 2026 results, surpassing earnings and revenue forecasts and raising its full-year EPS outlook. Analysts from Jefferies, Cantor Fitzgerald, and BofA Securities have responded positively, increasing their price targets for the stock.